No Photo Available

Last Update

2016-09-22T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong William Kerns?

Dr. William D. Kerns

Vice President, Drug Development

Can-Fite BioPharma Ltd

Direct Phone: (978) ***-****       

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Can-Fite BioPharma Ltd

10 Bareket Street Kiryat Matalon

Petah Tiqwa, 4951778

Israel

Company Description

Can-Fite BioPharma Ltd is an Israeli public company, the ordinary shares of which are traded on the Tel Aviv Stock Exchange (the "TASE") (TASE: CFBI). Level II American Depository Receipts of the Company currently trade on the NYSE MKT (NYSE MKT: CANF). C ... more

Find other employees at this company (11)

Background Information

Employment History

Position, Pharmaceutical Research and Development

SmithKline Beecham Corporation

Chief Executive Officer

Accellient Partners LLC

Affiliations

Treasurer
NTSRI

Scientific Advisory Board Member
Taiwan Liposome Company

Advisor
Critical Path Institute

Board Member
Calvert Holdings , Inc.

Scientific Advisory Board
Ricerca Biosciences LLC

Education

American College of Veterinary Pathologists

DVM

DVM

The Ohio State University

MS

MS

Ohio State University

Web References (132 Total References)


Drug Development Team

www.can-fite.com [cached]

William D. Kerns, DVM, MS, DACVP, VP Drug Development

Dr. Kerns has over 20 years of experience in Pharmaceutical Research and Development at SmithKline Beecham and Eisai Pharmaceuticals. As a Senior Executive he has participated in the development of drugs for over 100 Phase I studies and 13 NDAs/MAAs. Bill has chaired a FDA committee on biomarkers and he is an expert in preclinical development and regulatory strategy.


Drug Development Team

www.canfite.com [cached]

William D. Kerns, DVM, MS, DACVP, VP Drug Development

Dr. Kerns has over 20 years of experience in Pharmaceutical Research and Development at SmithKline Beecham and Eisai Pharmaceuticals. As a Senior Executive he has participated in the development of drugs for over 100 Phase I studies and 13 NDAs/MAAs. Bill has chaired a FDA committee on biomarkers and he is an expert in preclinical development and regulatory strategy.


Company Leadership

www.canfite.com [cached]

William D. Kerns, DVM, MS, DACVP, VP Drug Development


Company Leadership

www.can-fite.com [cached]

William D. Kerns, DVM, MS, DACVP, VP Drug Development


Can-Fite BioPharma - Home Page

www.canfite.com [cached]

William D. Kerns, DVM, MS, DACVP Can-Fite BioPharma - Home Page

Can-Fite BioPharma

Similar Profiles

Other People with this Name

Other people with the name Kerns

Emily Kerns
Collabera

Megan Kerns
Incentra, Inc.

Krissy Kerns
Precision Metalforming Association

Karl Kerns
Fairfax County Public Schools

Stan Kerns
Kerns & Associates Inc

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory